Mouse Anti-EEF1D Recombinant Antibody (CF143) (CBMAB-FT337LY)

Xu, Q., Liu, Y., Wang, S., Wang, J., Liu, L., Xu, Y., & Qin, Y. (2022). Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin. BMC cancer, 22(1), 1-15.

Xu, H., Yu, S., Peng, K., Gao, L., Chen, S., Shen, Z., ... & Kang, M. (2021). The role of EEF1D in disease pathogenesis: a narrative review. Annals of Translational Medicine, 9(20).

Hou, Y., Xie, Y., Yang, S., Han, B., Shi, L., Bai, X., ... & Sun, D. (2021). EEF1D facilitates milk lipid synthesis by regulation of PI3K‐Akt signaling in mammals. The FASEB Journal, 35(5), e21455.

Xie, C., Zhou, M., Lin, J., Wu, Z., Ding, S., Luo, J., ... & Song, Y. (2020). EEF1D promotes glioma proliferation, migration, and invasion through EMT and PI3K/Akt pathway. BioMed Research International, 2020.

BİTERGE SÜT, B., & İKİNCİ KELEŞ, A. (2020). Prognostic and Predictive Significance of Eukaryotic Elongation Factor 1D (eEF1D) in Breast Cancer: A Potential Marker of Response to Endocrine Therapy. Oncologie, 22(3).

Ugur Iseri, S. A., Yucesan, E., Tuncer, F. N., Calik, M., Kesim, Y., Altiokka Uzun, G., & Ozbek, U. (2019). Biallelic loss of EEF1D function links heat shock response pathway to autosomal recessive intellectual disability. Journal of Human Genetics, 64(5), 421-426.

Cheng, D. D., Li, S. J., Zhu, B., Zhou, S. M., & Yang, Q. C. (2018). EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. Journal of Experimental & Clinical Cancer Research, 37(1), 1-10.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols